Sort
64,565 grants matching “drug discovery”
Supporting Biomedical Discovery with the ROBOKOP Graph Knowledgebase.
$786,413Alexander Tropsha · Univ Of North Carolina Chapel Hill · U24 · FY2025 · ES
Synthetic biology tools for scalable production of medicinal plant terpenes
$786,361Elizabeth Susan Sattely · Stanford University · R01 · FY2019 · AT
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
$786,174Issam A Awad · University Of Chicago · R01 · FY2019 · NS
Mechanisms of Prion Protein Toxicity
$786,131David A Harris · Boston University Medical Campus · R01 · FY2021 · NS
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
$786,082Chong-Xian Pan · University Of California At Davis · K12 · FY2018 · CA
Translating innovative research discoveries to a potential therapeutic for Down S
$785,948Elizabeth Keith Messersmith · Balance Therapeutics, Inc. · U44 · FY2013 · NS
Covalent protein-ligand binding affinities with VM2
$785,946Simon Webb · Verachem, Llc · R44 · FY2022 · GM
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
$785,933Yanling Wang · Rush University Medical Center · R01 · FY2022 · AG
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
$785,874Pietro P Sanna · Scripps Research Institute, The · R01 · FY2019 · DA
Modeling diabetes using an integrated plate system
$785,782James M Wells · Cincinnati Childrens Hosp Med Ctr · UG3 · FY2019 · DK
PRO: A Protein Ontology in OBO Foundry for Integration of Biomedical Knowledge
$785,773Cathy H Wu · University Of Delaware · R01 · FY2012 · GM
N-CANDA: Data Analysis Component
$785,661Adolf Pfefferbaum · Sri International · U24 · FY2016 · AA
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$785,479Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Pharmacokinetic/toxicology & in vivo efficacy of potential AD therapeutic agents
$785,438Sam Khatami · Neuronautics, Inc. · R44 · FY2007 · AG
Gene Methylation Signatures for Predictive Classification of Response to Therapy
$785,372Paul Cairns · Fox Chase Cancer Center · P50 · FY2012 · CA
Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease
$785,292Tauseef R. Butt · Lifesensors, Inc. · R44 · FY2020 · AG
Lead optimization of Novel mGlu2 Negative Allosteric Modulators
$785,204Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · MH
Lead optimization of Novel mGlu2 Negative Allosteric Modulators
$785,204Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · MH
Discovery of Novel Broad-Spectrum Coronavirus Mpro Inhibitors
$785,196Julien Papillon · University Of Texas Med Br Galveston · U19 · FY2023 · AI
Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense
$785,176John N Van Den Anker · Children'S Research Institute · U54 · FY2014 · HD
Genetics and Molecular Mechanisms of Prostate Cancer
$785,162William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development of Anticancer Agents
$785,162William Douglas Figg · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Development and Validation of a Nocturnal Sleep Signature for the Diagnosis of Idiopathic Hypersomnia
$785,153Kiran Prasad Maski · Boston Children'S Hospital · R61 · FY2024 · NS
Human Isogenic Organoid Models of Genetic Forms of Autism to Identify Convergent and Divergent Pathomechanisms in Autism
$785,119Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2025 · MH
Small molecule mitochondria-targeted therapeutics for AD
$785,056Eugenia Trushina · Mayo Clinic Rochester · UG3 · FY2021 · NS